SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-002609
Filing Date
2023-02-06
Accepted
2023-02-06 17:09:33
Documents
18
Period of Report
2023-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20230206_8k.htm   iXBRL 8-K 32752
2 EXHIBIT 10.1 ex_472000.htm EX-10.1 9270
3 EXHIBIT 10.2 ex_472001.htm EX-10.2 8818
4 EXHIBIT 10.3 ex_472002.htm EX-10.3 8994
5 EXHIBIT 10.4 ex_472003.htm EX-10.4 8987
10 aravive01.jpg GRAPHIC 7120
  Complete submission text file 0001437749-23-002609.txt   221869

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20230201.xsd EX-101.SCH 3600
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230201_def.xml EX-101.DEF 11531
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230201_lab.xml EX-101.LAB 15413
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230201_pre.xml EX-101.PRE 11687
12 EXTRACTED XBRL INSTANCE DOCUMENT arav20230206_8k_htm.xml XML 2550
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 23591478
SIC: 2834 Pharmaceutical Preparations